In interventional trials for eczema, improvement has been demonstrated for those in placebo groups.[2],[3] The effect of increased frequency of patient reporting, as demonstrated in this study, may be a contributing factor. Evaluating the effect of weekly patient-reported symptom monitoring on trial outcomes: results of the Eczema Monitoring Online randomized controlled trial.